Amide Technologies

Cambridge, United States Founded: 2017 • Age: 9 yrs
Automated peptide synthesis platform is developed with precision reagents.

About Amide Technologies

Amide Technologies is a Healthcare company based in Cambridge (United States) founded in 2017. Automated peptide synthesis platform is developed with precision reagents. Amide Technologies has raised $16.5 million across 3 funding rounds from investors including The Engine and Biological Engineering Ventures. The company has 8 employees. Amide Technologies offers products and services including Peptide Synthesis Service and High-Speed Delivery Service. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Proteomics. Its legal entity is AMIDE TECHNOLOGIES INC. Its competitors include Encodia, Tierra Biosciences and Aquagene; 2 of its 3 listed competitors have raised funding.

Company details

Amide Technologies was founded in 2017 and is based in Cambridge, United States. Operations focus on the biotechnology sector, where an automated platform for peptide synthesis is provided. A patent-protected instrument has been created to support solid-phase polypeptide synthesis through the integration of flow chemistry and precision reagents. This enables efficient production processes for research and development applications in the field.

  • Headquarters Cambridge, United States
  • Employees 8
  • Sectors
    Healthcare
  • Website amidetech.com
  • Social LinkedIn
  • Legal Name Amide Technologies Inc
Key Metrics
  • Total Equity Funding
    $16.5M (USD)

    in 3 rounds

  • Latest Funding Round
    $7.5M (USD), Series A

    Jul 2023

  • Investors
    The Engine

    & 1 more

  • Employee Count
    8

Products & Services of Amide Technologies

Amide Technologies offers a comprehensive portfolio of products and services, including Peptide Synthesis Service and High-Speed Delivery Service.

Peptide Synthesis Service
Biotech Services

Synthesizes hard-to-obtain peptides for drug discovery and development.

High-Speed Delivery Service
Manufacturing Services

Provides fast turnaround for urgent peptide orders in drug research.

Funding Insights of Amide Technologies

Amide Technologies has successfully raised a total of $16.5M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $7.5 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $16.5M
  • Total Rounds 3
  • Last Round Series A β€” $7.5M
  • First Round $5.45M

    (Nov 2017)

  • Investors Count 2

All 3 funding rounds of Amide Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2023$7.5MSeries A–Engine
–
Aug 2021$3.55MSeries A–Engine
–
Nov 2017$5.45MSeed–Biological Engineering Ventures
–
Valuation history

2 investors in total: 2 institutional.

Investors in Amide Technologies

Amide Technologies has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include The Engine and Biological Engineering Ventures.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
VC funding and acceleration support are provided to tech startups.
engine.xyzCambridge, United States
Limited information is provided about Biological Engineering Ventures.
bev.bio
Premium access

Investor details for Amide Technologies

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Amide Technologies

1 people are tracked at Amide Technologies (1 in team); the tracked headcount is 8.

NameRoleGroup
Mark Simon
Technical AdvisorTeam
Premium access

Complete people profiles for Amide Technologies

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Amide Technologies

3 dated milestones of Amide Technologies across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded Amide Technologies is founded.
  2. Funding First funding round of $5.5M.
  3. Funding Latest funding round, Series A, of $7.5M.

Competitors of Amide Technologies

Amide Technologies has 3 listed competitors in our database, 2 of them funded. They include Encodia, Tierra Biosciences and Aquagene.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
encodia.com2015San Diego, United States$75M85
Technology platforms for integrative proteomic analysis are developed.
tierrabiosciences.com2015Berkeley, United States$31.56M11
AI-based tools for protein development and custom synthesis are offered.
aquagene.com1996Alachua, United States
Produces high-quality recombinant proteins for research and industrial applications.
Premium access

Detailed competitors of Amide Technologies

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Amide Technologies

The website of Amide Technologies (amidetech.com) receives about 2.2K visits a month.

  • Monthly visits
    2.2K

    ▼ 13.9% vs previous month

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Amide Technologies (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Amide Technologies

Premium access

Complete news archive for Amide Technologies

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amide Technologies

Amide Technologies was founded in 2017.

Amide Technologies is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.

Amide Technologies is a funded company, having raised a total of $16.5M across 3 funding rounds to date. The company's 1st funding round was a Seed of $5.45M, raised on Nov 2017.

Amide Technologies has 8 employees.

Amide Technologies was founded in 2017 and is based in Cambridge, United States. Operations focus on the biotechnology sector, where an automated platform for peptide synthesis is provided. A patent-protected instrument has been created to support solid-phase polypeptide synthesis through the integration of flow chemistry and precision reagents. This enables efficient production processes for research and development applications in the field.

Amide Technologies's top competitors include Encodia, Tierra Biosciences and Aquagene.

Amide Technologies offers Peptide Synthesis Service and High-Speed Delivery Service.

Amide Technologies has 2 investors. Key investors include The Engine, and Biological Engineering Ventures.

Amide Technologies operates through Amide Technologies Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available